-
Mashup Score: 0Management of menopause: a view towards prevention - 1 year(s) ago
Women spend approximately one-third of their lives with menopause, which occurs around 50 years of age. It is now appreciated that several important metabolic and cardiovascular disease risks emerge during the menopausal transition. Many important conditions occur 10–15 years after menopause, including weight gain and obesity, metabolic syndrome, diabetes, osteoporosis, arthritis, cardiovascular…
Categories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 0Wolters Kluwer Health - 1 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Find #UpToDate® on Oncology Times, presenting select content synopses on “What's New in #Oncology.” This edition features "No benefit with adjuvant ibandronate in #postmenopausal #women with #breastcancer" & more: https://t.co/LrJKqRu66K #oncologyresearch #medicalnews https://t.co/1Cgnc6kzde
-
-
Mashup Score: 1
Kaiser Permanente study finds cancer and its treatments accelerate decline in physical function By Sue Rochman Postmenopausal women with cancer report a greater decline in physical function than women who have not had cancer, new Kaiser Permanente research shows. Elizabeth Cespedes Feliciano, ScD “We know that cancer is a disease of aging, and that as we grow older our risk of getting cancer…
Source: spotlight.kaiserpermanente.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
New research shows #postmenopausal women with #cancer report a greater decline in physical function than women who have not had cancer. Read more about the Fred Hutch-based @WHIStudy via @KPDOR: https://t.co/UfDcPgOUjJ https://t.co/IkhFdYmmsN
-
-
Mashup Score: 1Wolters Kluwer Health - 2 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Find #UpToDate® on Oncology Times, presenting select content synopses on “What's New in #Oncology.” This edition features "No benefit with adjuvant ibandronate in #postmenopausal #women with #breastcancer" & more: https://t.co/LrJKqRu66K #oncologyresearch #medicalnews https://t.co/cr76ZEccjC
-
-
Mashup Score: 0Management of menopause: a view towards prevention - 2 year(s) ago
Women spend approximately one-third of their lives with menopause, which occurs around 50 years of age. It is now appreciated that several important metabolic and cardiovascular disease risks emerge during the menopausal transition. Many important conditions occur 10–15 years after menopause, including weight gain and obesity, metabolic syndrome, diabetes, osteoporosis, arthritis, cardiovascular…
Categories: Endocrinology, Latest HeadlinesTweet-
When instituted early, which is key, in younger #postmenopausal women (under 60 years) #oestrogen has been found to consistently decrease #mortality with a favourable risk–benefit profile in low-risk women https://t.co/5JIQVhNAxr #Menopause #WomensHealth
-
-
Mashup Score: 1Wolters Kluwer Health - 2 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Find #UpToDate® on Oncology Times, presenting select content synopses on “What's New in #Oncology.” This edition features "No benefit with adjuvant ibandronate in #postmenopausal #women with #breastcancer" & more: https://t.co/LrJKqRu66K #oncologyresearch #medicalnews https://t.co/JVRkXMA3lh
-
-
Mashup Score: 0Denosumab biosimilar displays noninferiority in postmenopausal patients with osteoporosis - 2 year(s) ago
A denosumab biosimilar candidate demonstrated noninferior efficacy to its reference product, with similar safety profile, in postmenopausal patients with osteoporosis, according to data published in Arthritis Research & Therapy.
Source: www.healio.comCategories: General Medicine News, Latest HeadlinesTweet-
A denosumab biosimilar candidate demonstrated noninferior efficacy to its reference product, with similar safety profile, in #postmenopausal patients with #osteoporosis @healiowomen https://t.co/tIOBEgin17
-
-
Mashup Score: 5Age at menopause and risk of heart failure and atrial fibrillation: a nationwide cohort study - 2 year(s) ago
This study showed that a history of premature menopause and early menopausal age was associated with an increased risk of both heart failure and atrial fibrilla
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet-
#Postmenopausal women with a history of premature menopause or early menopausal age may have an increased risk of HF and #AFib #HeartFailure #EHJ https://t.co/ot2sLUWwXD @ESC_Journals @escardio @ShelleyZieroth @hvanspall @DrMarthaGulati @ErinMichos @DBelardoMD @BiykemB https://t.co/sG0jnMGZE8
-
-
Mashup Score: 0Female patients with RA receiving exogenous sex hormones more likely to achieve remission - 2 year(s) ago
Female patients with rheumatoid arthritis are more likely to achieve remission when treated with exogenous sex hormones, particularly those who are perimenopausal and early postmenopausal, according to data published in Rheumatology.
Source: www.healio.comCategories: Latest Headlines, RheumatologyTweet-
“Perimenopausal and early #postmenopausal patients who were taking exogenous sex hormone therapies had an improved remission likelihood compared to counterparts,” Dala N. Daraghmeh, PharmD, of @UniversitySA, told Healio https://t.co/oQsLSg2cuR
-
-
Mashup Score: 1
Emerging research with brain magnetic resonance imaging (MRI) scans shows that postmenopausal women have higher amounts of white matter hyperintensities that may lead to elevated risks for cognitive dysfunction and stroke.
Source: Diagnostic ImagingCategories: Latest Headlines, RadiologyTweet-
New #MRI Study Reveals Increased Brain Changes in #Postmenopausal Women https://t.co/9IXu4jy7l6 @ACRRFS @ACRYPS @RadiologyACR @ARRS_Radiology @RSNA @AAWR_org @TheASNR @UWiscNeuroRad @UCLANeurorads @UofUNeuro @JNeuroradiology @USCneurorads #radiology #RadRes https://t.co/2yzwSMkiKm
-
When instituted early, which is key, in younger #postmenopausal women (under 60 years) #oestrogen has been found to consistently decrease #mortality with a favourable risk–benefit profile in low-risk women https://t.co/5JIQVhNAxr #Menopause #WomensHealth